DuPont gets Gates grant for protein drug production platform

By Gareth Macdonald contact

- Last updated on GMT

iStock/markusblanke
iStock/markusblanke

Related tags: Bill & melinda gates foundation

DuPont has joined a Gates Foundation backed effort to develop low cost production methods for therapeutic proteins.

The Bill & Melinda Gates Foundation awarded the firm’s DuPont Industrial Biosciences division a grant to support development of production systems for protein-based medicines, with a particular focus on scalable manufacturing platforms.

Division president William F. Feehery said: “We cannot underestimate the complexity of this challenge. At the same time, we cannot turn our backs on the possibility of improving access and affordability of life-saving medications for communities around the world.

This is cutting-edge science. We are honoured to work with a leading organization like The Gates Foundation to tackle this type of issue, as no one company or entity can get there on their own​.”

DuPont is one of a number of companies the Gates Foundation has tasked with lowering the cost of making large molecule drugs.

Last week, the Foundation granted Belgian technology firm Univercells - and consortium partners Batavia Biosciences and Natrix Separations - $12m (€12.5m) to develop a vaccine production platform.

DuPont is due to merge with Dow Chemical under a deal announced in late 2015​.

Previously the aim was to complete the merger by the end of this year. However, in October the firms said completion would likely be delayed until early 2017​.

Related products

show more

Faster, Higher and Stronger for Longer

Faster, Higher and Stronger for Longer

Gelita AG | 02-Nov-2018 | Application Note

Bioactive Collagen Peptides® are expanding more and more into active nutrition, where they can play a unique role in helping athletes and active people...

 Cannabidiol: Should you invest in it?

Cannabidiol: Should you invest in it?

The Whitehouse Consultancy | 17-Oct-2018 | Technical / White Paper

An increasing number of CBD containing products are appearing on the market and consumer interest in this substance is rising.

Omegavie® DHA algae Capsules

Omegavie® DHA algae Capsules

POLARIS | 23-Aug-2018 | Application Note

Omegavie® DHA algae capsules is a real opportunity to consume high-performing Omega-3 DHA 100% vegan, natural, sustainable, GMO- and allergen-free. Designed...

Related suppliers

Follow us

Featured Events

View more

Products

View more

Webinars